Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06325098

Implementation of a Diagnostic Workflow for Personalized Diagnosis of Nephrotic Syndrome

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Meyer Children's Hospital IRCCS · Academic / Other
Sex
All
Age
1 Month – 40 Years
Healthy volunteers
Not accepted

Summary

Nephrotic syndrome (NS) is a clinical picture common to several diseases resulting from damage to podocytes and glomerular filtration barrier. Currently, there is limited consensus regarding the diagnostic pathway and management of the specific etiology. Some patients show complete response to first-line steroid therapy (steroid-sensitive nephrotic syndrome, SSNS), especially in children and young adults. The prognosis of this group is generally favorable. In contrast, patients unresponsive to steroids (steroid-resistant NS, SRNS) frequently undergo immunosuppressive therapies, which are burdened with numerous side effects. Resistance to treatment is associated with a high likelihood of progression to chronic renal disease (CKD) and kidney failure (ESKD). Recent evidence suggests that immunological mechanisms (including permeabilizing factors) are involved in the pathogenesis of post-transplant NS recurrence and SSNS. Providing patients with NS with a correct diagnosis is the cornerstone of personalized medicine, reducing morbidity and side effects of therapies, ensuring their appropriate prescription, and slowing or preventing progression to ESKD.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTAnti-nephrin antibodiesAssessment of anti-nephrin antibodies on serum samples and in vitro study of permeabilizing effect on 3D organ-on-a-chip models and STED microscopy on healthy human kidneys.
DIAGNOSTIC_TESTu-RPC culturesUrine sample collection for u-RPC cultures

Timeline

Start date
2022-01-26
Primary completion
2026-01-31
Completion
2026-06-30
First posted
2024-03-22
Last updated
2024-03-22

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06325098. Inclusion in this directory is not an endorsement.